Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study
about
Epigenome-based personalized medicine in human cancerCurrent Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapyMolecular therapeutic approaches for pediatric acute myeloid leukemia.Gemtuzumab ozogamicin in acute myeloid leukemia revisited.Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.Recent developments in immunotherapy of acute myeloid leukemia.Chemotherapy Options for Poor Responders to Neoadjuvant Chemotherapy for Orbital Granulocytic Sarcoma.Hypomethylating Agents as a Therapy for AML.Role of epigenetic regulation on the induction of apoptosis in Jurkat leukemia cells by white grape pomace rich in phenolic compounds.Complete molecular remission in relapsed and refractory acute myeloid leukaemia with MLL-AF9 treated with chidamide-based chemotherapy.
P2860
Q28083951-89778110-C03A-450D-A159-A62532C709DFQ35546759-3622749D-49AA-405B-9B5F-69896EB41074Q37216454-4902DFA7-94EC-4BE1-A0F4-B0A612DAEA10Q37643136-6A4F7F60-6F73-49D4-9A82-8C091A6BAEC5Q38215269-1F3192F3-4258-4622-A700-273991CDBAAFQ38537883-C63A4F2B-CA6B-4336-B812-755C21C8C992Q38661895-94268F79-38AC-466E-A806-1DCA4B952F9BQ38864977-9B8BA13B-823B-48FE-944D-8F3472C9A12BQ38911864-0B74499E-E29E-4907-ACA7-E455CF59DCE8Q46295217-B89FBBD7-2566-42B1-B073-1D476A1451F4Q52764678-CD308409-BE6C-4506-98E6-6FA523912968
P2860
Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Gemtuzumab ozogamicin in combi ...... d leukemia: a phase I/II study
@ast
Gemtuzumab ozogamicin in combi ...... d leukemia: a phase I/II study
@en
Gemtuzumab ozogamicin in combi ...... leukemia: a phase I/II study.
@nl
type
label
Gemtuzumab ozogamicin in combi ...... d leukemia: a phase I/II study
@ast
Gemtuzumab ozogamicin in combi ...... d leukemia: a phase I/II study
@en
Gemtuzumab ozogamicin in combi ...... leukemia: a phase I/II study.
@nl
prefLabel
Gemtuzumab ozogamicin in combi ...... d leukemia: a phase I/II study
@ast
Gemtuzumab ozogamicin in combi ...... d leukemia: a phase I/II study
@en
Gemtuzumab ozogamicin in combi ...... leukemia: a phase I/II study.
@nl
P2093
P2860
P1433
P1476
Gemtuzumab ozogamicin in combi ...... d leukemia: a phase I/II study
@en
P2093
Bart L Scott
Bruno C Medeiros
Elihu H Estey
Kaysey F Orlowski
Kelda M Gardner
Leonel Gallegos
Paul C Hendrie
P2860
P356
10.3324/HAEMATOL.2013.096545
P577
2013-10-18T00:00:00Z